ArticleOPEN ACCESS

Complexity made simple in diffuse large B-cell lymphoma

Clinical Cancer Research
DOI: 10.1158/1078-0432.CCR-09-1444
5Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Diffuse large B cell lymphoma (DLBCL) is a heterogeneous disease and response to therapy is difficult to predict. An algorithm to sort DLBCL cases using a series of five immunohistochemical markers (GCET1, CD10, BCL6, MUM1, FOXP1) accurately predicts survival in patients treated with current chemotherapeutic regimens. © 2009 American Association for Cancer Research.

Cite

CITATION STYLE

APA

Aster, J., & Kutok, J. (2009, September 1). Complexity made simple in diffuse large B-cell lymphoma. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.CCR-09-1444

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free